As of Jul 02
| +4.57 / +0.90%|
The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 520.00, with a high estimate of 600.00 and a low estimate of 381.00. The median estimate represents a +1.75% increase from the last price of 511.08.
The current consensus among 23 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.